Success Story: NIW Approved Without RFE! Our Team Assisted a Chinese Senior Data Scientist in Securing Success
Client’s Testimonial:
“Thank you so much for your help! It’s great to hear that my I-140 NIW was approved smoothly!”
On September 20th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Data Scientist in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Senior Data Scientist
Country of Origin: China
Approval Notice Date: September 20th, 2025
Processing Time: 20 months, 3 days
Case Summary:
With a Ph.D. in neuroscience, the client is an accomplished expert in biomedical science whose research bridges bioinformatics, data science, and neuroscience. The client’s proposed endeavor focuses on developing computational and analytical tools to characterize the mechanisms of chronic and complex diseases. By integrating large-scale biological data, the client’s work aims to accelerate the discovery of effective treatment strategies for conditions that pose significant public health challenges, such as neurodegenerative disorders and metabolic diseases.
Throughout an impressive academic and professional career, the client has authored three peer-reviewed journal articles and three conference abstracts. The client’s studies have been cited over 210 times, a testament to the influence and value of the client’s scientific contributions. These publications have been featured in leading journals in neuroscience and biomedical science, where fellow researchers have built upon the client’s findings to advance innovations in imaging technology, computational modeling, and disease treatment development.
In addition to producing high-impact publications, the client has contributed to the academic community as a peer reviewer, having completed at least three reviews for established scientific journals. Such invitations are extended only to recognized experts whose opinions carry weight in the field, further underscoring the client’s strong professional standing.
The client’s research achievements have also garnered major funding from national scientific agencies, including the National Science Foundation (NSF), National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and National Institute of Neurological Disorders and Stroke (NINDS). These prestigious organizations fund projects that advance national priorities in public health and scientific innovation, reflecting the substantial merit and national importance of the client’s work.
To support the petition, four letters of recommendation were provided by independent and affiliated experts in biomedical research. These letters praised the client’s groundbreaking use of data science to elucidate the biological underpinnings of disease and recognized the client’s ability to contribute to national goals of improving healthcare outcomes and sustaining leadership in biomedical technology.
“Time and again, [Client] has demonstrated her penchant for producing high-quality, significant research that has proven to be of great benefit to her peers. She is a scholar of the highest quality, whose efforts have improved the state of research in the field of biomedical science. Therefore, the United States must ensure that [Client] has the ability to continue her research.”
The petition demonstrated that the client’s contributions address urgent national needs in public health and biomedical innovation. Given the client’s outstanding research record, influential publications, and ongoing commitment to advancing bioinformatics-driven approaches to disease treatment, USCIS approved the I-140 National Interest Waiver petition, recognizing that waiving the job offer and labor certification requirements serves the best interest of the United States.